Transurethral injection of bulking agent for treatment of failed mid-urethral sling procedures.

International Urogynecology Journal
Ha Na LeeKyu-Sung Lee

Abstract

We evaluated the efficacy of transurethral injection (TUI) for the treatment of recurrent or persistent stress urinary incontinence after mid-urethral sling (MUS) procedures. A retrospective study was conducted among 23 women who had undergone TUI for failed MUS using bulking agents, Macroplastique® and Durasphere®. The Sandvik questionnaire, Subjective Symptom Visual Analogue Scale (VAS), Incontinence Quality of Life (I-QOL) assessment, and Benefit, Satisfaction, and Willingness to Continue questionnaire were used to evaluate the efficacy of TUI. The cure rate was 34.8% for a median follow-up of 10 months. Subjective symptom VAS, total, and all domains of I-QOL scores were significantly improved after TUI. Ninety-two percent of the patients reported a benefit and 77% of the patients were satisfied with the treatment. TUI for failed MUS demonstrated a low cure rate but high patient satisfaction, and the procedure was minimally invasive with no significant complications.

References

Feb 25, 1998·The Journal of Urology·L StothersE F Leone
Nov 26, 1999·BJU International·E GortonD R Bland
May 10, 2002·International Urogynecology Journal and Pelvic Floor Dysfunction·K T EcholsS A Shobeiri
Jun 11, 2002·International Urogynecology Journal and Pelvic Floor Dysfunction·L RiachiJ Miklos
May 29, 2003·The Journal of Urology·José Tadeu Nunes TamaniniNelson Rodrigues Netto
Oct 6, 2004·Current Urology Reports·Harriette M Scarpero, Roger R Dmochowski
Jun 1, 2005·BJOG : an International Journal of Obstetrics and Gynaecology·Christopher F MaherPhilip Schluter
Dec 13, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Andreas M PleilCon J Kelleher
Apr 4, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Alexander TsivianA Ami Sidi
Jul 19, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Christopher R ChappleDudley Robinson
Jul 27, 2006·International Urogynecology Journal and Pelvic Floor Dysfunction·Robert D MooreJohn R Miklos
Jul 20, 2007·The Cochrane Database of Systematic Reviews·P E KeeganR Pickard
Feb 29, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Roslin BotleroRobin J Bell
Jul 22, 2008·Neurourology and Urodynamics·Niels Klarskov, Gunnar Lose
Dec 19, 2008·The Journal of Urology·Ginger Isom-Batz, Philippe E Zimmern

❮ Previous
Next ❯

Citations

Mar 14, 2012·International Urogynecology Journal·Ilias GiarenisDudley Robinson
Jun 19, 2012·International Urogynecology Journal·Stefan MohrAnnette Kuhn
Oct 26, 2012·International Urogynecology Journal·Aimee L SmithG Willy Davila
Jun 12, 2014·Current Urology Reports·Lara S MacLachlan, Eric S Rovner
Apr 3, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·T ThubertX Deffieux
Aug 11, 2012·The Urologic Clinics of North America·Eugene LeeBenjamin M Brucker
Jul 16, 2015·International Urogynecology Journal·Tae Heon KimKyu-Sung Lee
Mar 1, 2012·Lower Urinary Tract Symptoms·Ji-Yeon HanMyung-Soo Choo
Jun 4, 2014·The Journal of Obstetrics and Gynaecology Research·Abdulmuttalip SimsekZafer Gokhan Gurbuz
Apr 3, 2016·Neurourology and Urodynamics·Irena ZivanovicVolker Viereck
Mar 5, 2015·Acta Obstetricia Et Gynecologica Scandinavica·Kostis I NikolopoulosStergios K Doumouchtsis
Aug 19, 2015·Nature Reviews. Urology·Jerry G BlaivasVladimir Iakovlev
Jul 16, 2015·World Journal of Urology·T G RashidF Van der Aa
May 8, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Alois MartanJan Krhut
Mar 11, 2015·International Urogynecology Journal·Maarten J van der DoelenJohn P F A Heesakkers
Sep 24, 2014·The Journal of Urology·Jaclyn C MiloseAnne P Cameron
Jun 3, 2016·International Urogynecology Journal·Meghan A GriffinHumphrey O Atiemo
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Evangelia BakaliDouglas G Tincello
Jan 16, 2015·Urologia·Francesco MarsonBruno Frea
May 9, 2014·Obstetrics and Gynecology·Anthony GaddiEmily L Whitcomb
Jun 16, 2014·Current Urology Reports·Geneviève Nadeau, Sender Herschorn
Oct 4, 2012·Annals of the Royal College of Surgeons of England·H Hashim, T R Terry
Feb 22, 2017·International Urogynecology Journal·Zain A SiddiquiShahzad Shah
Aug 25, 2020·Current Opinion in Obstetrics & Gynecology·Jacqueline M Speed, Kavita Mishra
Aug 13, 2011·Current Opinion in Obstetrics & Gynecology·Colin A Walsh
Apr 1, 2021·World Journal of Urology·Marcelo Langer WroclawskiJeremy Yuen-Chun Teoh
Mar 31, 2021·International Neurourology Journal·Joonbeom KwonDuk Yoon Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.